Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are expected to improve the liver function of patients with non-alcoholic fatty liver disease (NAFLD) combined type 2 diabetes mellitus (T2DM) by its characteristic mechanism. This study was designed to investigate the effect of dapaglif...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Dug-Hyun, Jung, Chan-Hee, Mok, Ji-Oh, Kim, Chul-Hee, Kang, Sung-Koo, Kim, Bo-Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145967/
https://www.ncbi.nlm.nih.gov/pubmed/30229578
http://dx.doi.org/10.3803/EnM.2018.33.3.387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145967/
https://www.ncbi.nlm.nih.gov/pubmed/30229578
http://dx.doi.org/10.3803/EnM.2018.33.3.387

Ejemplares similares